Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
subject: antiviral activity, type I IFN, Immunoregulation, multiple scleorsis (MS), SARS-CoV-2
creator: Cinthia Farina, Martina Severa, Marco Salvetti, Eliana Marina Coccia
source: Frontiers in Immunology
publisher: Frontiers Media S.A.
date: 2020
identifier: DOI: 10.3389/fimmu.2020.01459
coverage: Immunologic diseases. Allergy